ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 896 filers reported holding ASTRAZENECA PLC in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,689 | -3.5% | 453,178 | +2.0% | 0.31% | +1.3% |
| Q2 2023 | $31,799 | -3.2% | 444,309 | -6.1% | 0.31% | -6.7% |
| Q1 2023 | $32,860 | +17.8% | 473,409 | +15.1% | 0.33% | +12.3% |
| Q4 2022 | $27,886 | -99.9% | 411,309 | +7.6% | 0.29% | +19.1% |
| Q3 2022 | $20,966,000 | +902.2% | 382,309 | +997.4% | 0.25% | +1194.7% |
| Q3 2021 | $2,092,000 | -60.4% | 34,838 | -77.5% | 0.02% | -71.2% |
| Q2 2017 | $5,284,000 | +9.5% | 155,000 | 0.0% | 0.07% | +8.2% |
| Q1 2017 | $4,827,000 | +14.0% | 155,000 | 0.0% | 0.06% | +13.0% |
| Q4 2016 | $4,235,000 | -16.8% | 155,000 | 0.0% | 0.05% | -15.6% |
| Q3 2016 | $5,093,000 | -64.3% | 155,000 | -29.5% | 0.06% | -61.9% |
| Q1 2014 | $14,274,000 | +9.3% | 220,000 | 0.0% | 0.17% | +10.5% |
| Q4 2013 | $13,061,000 | +14.3% | 220,000 | 0.0% | 0.15% | +46.2% |
| Q3 2013 | $11,425,000 | +9.8% | 220,000 | 0.0% | 0.10% | +6.1% |
| Q2 2013 | $10,406,000 | – | 220,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |